Danaher Corp

DHR

Add to Watchlist

171.160USD

-4.500-2.56%

Close 05/08, 16:00（ET）Quotes delayed by 15 min

Danaher Corp's Score

Industry at a Glance

Industry Ranking

32 / 206

Overall Ranking

110 / 4494

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Negative

Danaher Corp Highlights

StrengthsRisks

Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a broad range of instruments, consumables, services and software that are primarily used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 20.13%.

Stable Dividend

The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 20.13%.

Undervalued

The company’s latest PE is 32.96, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 597.30M shares, decreasing 0.04% quarter-over-quarter.

Held by Manning & Napier Group, LLC

Star Investor Manning & Napier Group, LLC holds 58.00 shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of -0.06.

Analyst Rating

Based on 26 analysts

Buy

Current Rating

247.571

Target Price

+42.25%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current financial score of Danaher Corp is 9.20, ranking 7 out of 206 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 5.95B, representing a year-over-year increase of 3.66%, while its net profit experienced a year-over-year increase of 7.86%.

Score

Industry at a Glance

Previous score

9.20

Change

0



Financials

8.42

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

8.87

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

9.20

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

9.83

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

9.66

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

The current valuation score of Danaher Corp is 5.27, ranking 183 out of 206 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 32.96, which is 59.41% below the recent high of 52.55 and 35.66% above the recent low of 21.21.

Score

Industry at a Glance

Previous score

5.27

Change

0

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 32/206

Relevant data have not been disclosed by the company yet.

The current earnings forecast score of Danaher Corp is 8.54, ranking 24 out of 206 in the Healthcare Equipment & Supplies industry. The average price target is 255.50, with a high of 310.00 and a low of 220.00.

Score

Industry at a Glance

Previous score

8.54

Change

0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current price momentum score of Danaher Corp is 6.44, ranking 146 out of 206 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 190.86 and the support level at 161.10, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.68

Change

-0.24

Support & Resistance

Relevant data have not been disclosed by the company yet.

Institutional Confidence

Currency: USD Updated: 2026-05-08

The current institutional shareholding score of Danaher Corp is 7.00, ranking 76 out of 206 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 83.99%, representing a quarter-over-quarter decrease of 0.84%. The largest institutional shareholder is The Vanguard, holding a total of 58.27M shares, representing 8.23% of shares outstanding, with 1.29% decrease in holdings.

Score

Industry at a Glance

Previous score

7.00

Change

0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

60.67M

+0.13%

Rales (Steven M)

42.24M

+0.00%

Rales (Mitchell P)

33.00M

-2.64%

BlackRock Institutional Trust Company, N.A.

29.18M

+0.28%

State Street Investment Management (US)

27.68M

+1.74%

Capital International Investors

18.25M

+8.88%

Fidelity Management & Research Company LLC

17.42M

+28.35%

Wellington Management Company, LLP

15.08M

+11.19%

T. Rowe Price Associates, Inc.

Star Investors

15.04M

+10.00%

Geode Capital Management, L.L.C.

13.77M

-0.54%



1

2



The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Danaher Corp is 9.44, ranking 8 out of 206 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.81. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. Danaher Corp’s latest ESG disclosure leads the Healthcare Equipment & Supplies industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.

Danaher Corp

DHR

7.73 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Lantheus Holdings Inc

LNTH

8.67 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Anika Therapeutics Inc

ANIK

8.56 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Tactile Systems Technology Inc

TCMD

8.48 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

LivaNova PLC

LIVN

8.41 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

West Pharmaceutical Services Inc

WST

8.39 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment